Accepted for/Published in: JMIR Research Protocols
Date Submitted: Oct 23, 2023
Date Accepted: Feb 9, 2024
Artificial intelligence and sexual and reproductive health and rights: Protocol for scoping review
ABSTRACT
Background:
Artificial intelligence (AI) has garnered significant attention in sexual and reproductive health and rights (SRHR) due to its nuanced implications, yet there is limited systematic documentation on the ways it is being applied globally and its related considerations.
Objective:
This paper presents the protocol for a scoping review examining the intersection of AI and SRHR to identify patterns of use, practices, implications, and knowledge gaps.
Methods:
The scoping review follows the standard methodology developed by Arksey and O’Malley. We will search the following electronic databases: MEDLINE (PubMED); Google Scholar; Web of Science, and CINAHL. The discussion will also be contextualized and informed through a technical consultation on AI and SRHR. Inclusion criteria comprise of AI systems and tools used across SRH interventions and clear methodology describing either quantitative or qualitive approaches, including program descriptions. We will also review the grey literature and policy documents to identify implementation considerations and implications. Studies will be excluded if they focus entirely on digital interventions that do not explicitly use AI systems and tools, on robotics or nonhuman studies, and commentaries. We will not exclude based on geographic location, language, or timeframe. We will use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement for the Scoping Reviews (PRISMA-ScR) format for the publication of the findings.
Results:
The database searches resulted in 12,793 records when the searches were conducted in October 2023. Screening is underway and the scoping review is planned to be completed by March 2024.
Conclusions:
The findings will provide key insights on the patterns of use and evidence base on AI in SRHR, as well as articulating the specific risks for mitigation. Outcomes of this scoping review will also contribute to a technical brief developed by World Health Organization and inform planning and decision-making. Clinical Trial: OSF DOI 10.17605/OSF.IO/MA4D9
Citation
Per the author's request the PDF is not available.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.